The purpose of this study is to determine whether the choice of post-operative eye drop administered after selective laser trabeculoplasty (SLT) for glaucoma affects the efficacy in lowering intraocular pressure (IOP).
SLT is used to lower intraocular pressure in glaucoma, but it is not know whether the choice of eyedrops administered in the post-operative period affects SLT efficacy. Practitioners commonly use steroid drops, non-steroidal anti-inflammatory drops, or no drops at all. This is a randomized, single-center, prospective, masked clinical trial to determine whether the choice of eyedrop affects efficacy of SLT in glaucoma patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
97
Prednisolone 1% to lasered eye 4 times/day for 4.5 days
Ketorolac 0.5% to lasered eye 4 times/day for 4.5 days
Artificial saline tears to lasered eye 4 times/day for 4.5 days
Bascom Palmer Eye Institute
Miami, Florida, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Intraocular Pressure (IOP) Change
IOP will be measured before and at 6 and 12 weeks after intervention using Goldman tonometry.
Time frame: Baseline to Week 12
Intraocular Inflammation
The count of patients with inflammation defined as anterior chamber cells was measured in each study arm.
Time frame: Up to week 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.